Aromatase inhibitor AnastrozoleTreatment of breast cancerStructural formula: C17H19N5CAS NO: 120511-73-1Molecular weight: 293.37Appearance: an off-white color crystalline powderPackage: 25KG/Drum Standard: Enterprise Standard Delivery Time:Within 3-5 Days After PaymentCertificates:ISO9001Grade:Pharmaceutical GradeExpress Way:EMS, FedEx, TNT, DHL, HkemsUsage: An aromatase inhibitor. Used as an antineoplastic raw materials.Potent selective triazole aromatase inhibitors, can inhibit the cytochrome P-450 aromatase enzyme which depends blocking the biosynthesis of estrogen, and estrogen to stimulate breast cancer cell growth factors. Treatment of breast cancer, especially for those with hormone relapse after adjuvant therapy after menopause for women with advanced breast cancer.Description:Anastrozole is more effective than previous drugs such as tamoxifen and crucially, it has fewer side effects . Anastrozole has been tested for reducing estrogens, including estradiol in men.Some athletes and body builders use anastrozole as part of their steroid cycle to reduce and prevent symptoms of excess estrogen--gynecomastia, emotional lability and water retention.Bone weakness has been associated with anastrozole.Applications:1). Anastrozole is prescribed for hormone receptor-positive, early breast cancer in postmenopausal women as adjuvant treatment ( treatment following surgery with or without radiation ). Anastrozole is prescribed as a first-line treatment for hormone receptor-positive or hormone receptor unknown, locally advanced or metastatic breast cancer in postmenopausal women. Anastrozole is also prescribed for the treatment of advanced breast cancer in postmenopausal women with disease progression following treatment with tamoxifen (Nolvadex, Soltamox). 2). ARIMIDEX is approved for adjuvant treatment (treatment following surgery with or without radiation) of postmenopausal women with hormone receptor-positive early breast cancer.ARIMIDEX is approved for the initial treatment of postmenopausal women with hormone receptor-positive or hormone receptor-unknown locally advanced or metastatic breast cancer and for the treatment of postmenopausal women with advanced breast cancer that has progressed following treatment with tamoxifen. Patients with hormone receptor-negative disease and patients who did not previously respond to tamoxifen therapy rarely responded to ARIMIDEX.
Quick Detail: Product name Benzocaine Factory Supplying Other name Americaine;ETHYL 4-AMINOBENZOATE;ETHYL P-AMINOBENZOATE CAS register number 94-09-7 EINECS 202-303-5 Molecular formula C9H
Quick Detail: Product name Benzocaine Factory Supplying Other name Americaine;ETHYL 4-AMINOBENZOATE;ETHYL P-AMINOBENZOATE CAS register number 94-09-7 EINECS 202-303-5 Molecular formula C9H
Betamethasone Synonyms: Bifas; Bebate; BecortCAS: 378-44-9 Molecular formula: C22H29FO5 MW: 392.46Packing: 5KG/TIN,2TIN/CTN Quality Standards: CP2005/USP/BP/EP Chemical Prope
Hilfe
Zu Favoriten 
Dem Warenkorb hinzugefügte Favoriten
